Skip to content
Search

Latest Stories

Wes Streeting proposes ban on NHS managers who silence whistleblowers

NHS managers who silence whistleblowers could be barred from working in the health service
hospital consultant chatting to administrator (gettyimages)

A public consultation will seek views on introducing a statutory duty of candour to make NHS managers accountable for responding to patient safety concerns

Health Secretary Wes Streeting has proposed measures to regulate NHS managers, ensuring they follow professional standards and support a culture of transparency.

Under these proposals, NHS managers who silence whistleblowers or endanger patients through misconduct could be barred from working in the health service.


The Department of Health and Social Care (DHSC) will launch a public consultation on these proposals on Tuesday, 26 November 2024, and run for 12 weeks. It will review responses to the consultation before outlining the next steps.

The consultation will also seek views on whether to introduce a new statutory duty of candour to make NHS managers legally accountable for responding to patient safety concerns.

The changes are designed to tackle a culture of cover-ups which has been found to be present in several patient safety scandals in recent years.

Health minister Karin Smyth emphasised the importance of reform: “To turn around our NHS we need the best and brightest managing the health service, a culture of transparency that keeps patients safe, and an end to the revolving door that allows failed managers to pick up in a new NHS organisation.”

Earlier this month, Streeting pledged to reform the NHS as part of their 10-year plan for health ensuring a system that “rewards success and acts decisively on failure.”

“Today’s announcement builds on that promise and help us build a health system that protects patients and is fit for the future,” Smyth added.

While tens of thousands of clinical and non-clinical managers work within the NHS, there is currently no single regulatory framework for them in the same way as doctors and nurses.

Options being considered by the consultation include: a voluntary accreditation register, statutory barring mechanisms, and full statutory registration.

At a minimum, the new regulatory system would apply to all board-level directors in NHS organisations in England, arm’s length body board-level directors, and integrated care board members.

The regulatory changes will come alongside support and development to equip managers with the tools necessary to meet professional standards.

Amanda Pritchard, chief executive of NHS England, endorsed the proposals stating:: “It is right that NHS managers have the same level of accountability as other NHS professionals, but it is critical that it comes alongside the necessary support and development to enable all managers to meet the high quality standards that we expect.

“We welcome this consultation and already have a range of work underway to boost support for managers in the NHS and to help set them up to succeed – this includes creating a single code of practice, a new induction process and a new set of professional standards, which will ultimately help drive improvements in productivity and patient care.”

Rachel Power, chief executive of the Patients Association, welcomed the public consultation noting that patients frequently report feeling a lack of accountability and transparency in their healthcare journeys.

She urged everyone who has experienced NHS care, especially those who have felt unheard by the system, to contribute their views.

The NHS Confederation also welcomed the government’s announcement of a public consultation on proposals to regulate health service managers.

Danny Mortimer, deputy chief executive of the NHS Confederation, reiterated that NHS leaders are committed to transparency and accountability.

He said: “When we consulted NHS boards they were clear that they should be held to the same standards with regards to public protection and safety as their clinical colleagues. We reflected this in the advice we offered the Secretary of State for Health as to any new arrangements might be implemented.

“We look forward to working with him to ensure that the new arrangements command the confidence of our members and, above all, the public,” he added.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
​The next generation of BD Rowa Smart launched

The latest BD Rowa™ Smart introduces a more intuitive user interface.

Photo credit: BD Rowa

BD Rowa unveils next-generation smart dispensing robot with sustainable design

Leading medical technology company BD Rowa has announced the launch of the next generation of its smart dispensing robot, offering enhanced convenience with a sustainable design.

Currently in its final development phase, the latest BD Rowa™ Smart introduces a more intuitive user interface designed to streamline operations and enhance the user experience.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less